Coronary stenting and use of abciximab. (Record no. 9753005)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01217 a2200361 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250513153744.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 199811s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0140-6736 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/S0140-6736(05)70524-9 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Mohl, W |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19981110 |
245 00 - TITLE STATEMENT | |
Title | Coronary stenting and use of abciximab. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Lancet (London, England) |
Date of publication, distribution, etc. | Oct 1998 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1312 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Case Reports; Letter; Comment |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Abciximab |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Angioplasty, Balloon |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anticoagulants |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunoglobulin Fab Fragments |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Platelet Aggregation Inhibitors |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Thrombocytopenia |
General subdivision | chemically induced |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Menges, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hennen, B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schieffer, H |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zeitz, M |
773 0# - HOST ITEM ENTRY | |
Title | Lancet (London, England) |
Related parts | vol. 352 |
-- | no. 9136 |
-- | p. 1312 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/S0140-6736(05)70524-9">https://doi.org/10.1016/S0140-6736(05)70524-9</a> |
Public note | Available from publisher's website |
No items available.